CLASS II ONGOING Drug recall · Reported 13 May 2026 · FDA Enforcement Report

Enalapril Maleate Tablets, USP, 20 mg recalled by JB Chemicals and

JB Chemicals and Pharmaceuticals is recalling Enalapril Maleate Tablets, USP, 20 mg, distributed nationwide in the US. The recall was initiated on 23 Apr 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: GEH25023, Expires: 6/30/2027
NDC64980-685, 64980-686, 64980-687, 64980-688
Quantity recalled675 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0520-2026
FDA event ID
98794
Recalling firm
JB Chemicals and Pharmaceuticals, Mumbai
Manufacturer
Rising Pharma Holdings, Inc.
Classification
Class II
Status
Ongoing
Recall initiated
23 Apr 2026
FDA classified
5 May 2026
Reported
13 May 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

23 Apr 2026Recall initiated by company
5 May 2026Classified by FDA+12 days
13 May 2026Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test

Which lots are affected?

Lot #: GEH25023, Expires: 6/30/2027

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from JB Chemicals and Pharmaceuticals

All 4
ReportedClassRecallCompanyReasonWhere
DrugCLASS ICetirizine Hydrochloride Tablets USP 5 mg recalled by JB Chemicals andCetirizine HydrochlorideJB Chemicals and PharmaceuticalsOtherNationwide
DrugCLASS IIICetirizine Hydrochloride Tablets USP 10 mg recalled by JB Chemicals andCetirizine HydrochlorideJB Chemicals and PharmaceuticalsOtherNationwide
DrugCLASS IIICetirizine Hydrochloride Tablets USP 10 mg recalled by JB Chemicals andCetirizine HydrochlorideJB Chemicals and PharmaceuticalsOtherNationwide

Other Enalapril recalls

All 21